WEN Hair-Loss Reports Underscore Need For Regulatory Reform – EWG
This article was originally published in The Rose Sheet
Executive Summary
EWG believes the Personal Care Products Act, which would mandate adverse-event reporting to FDA, could help to ensure that consumer injuries from cosmetic use do not reach the scale alleged in class actions targeting Guthy-Renker, which markets WEN by Chaz Dean Cleansing Conditioners. According to one suit filed in California district court, the firm has received more than 17,000 complaints of significant hair loss following product use.
You may also be interested in...
Senate HELP To Hear From Stakeholders In Changed Cosmetics Industry
Since 2012 when a House committee held the last cosmetics hearing, industry generally has warmed to – or resigned itself to – legislative proposals to update the cosmetics regulatory system. However, there is still not consensus on the details among big business, SMEs and consumer advocates, all of which will be represented at the Senate HELP Committee’s witness table.
2015 In Review: Tension Builds At The Regulatory Cosmetic/Drug Divide
FDA continued its crackdown on overreaching cosmetic claims in 2015, issuing nine warnings to cosmetic product marketers, while a draft bill emerged in the US House that would redefine "cosmetic" under federal law to provide companies with greater flexibility. Microbead legislation commanded the most national attention, with President Obama signing the federal Microbead-Free Waters Act to close out the year.
Complaints Allege Guthy-Renker’s WEN Conditioner Line Causes Hair Loss
A suit filed March 17 alleges the products cause extreme and possibly permanent damage to hair, including hair loss, visible bald spots and severe breakage. In an earlier suit, the firm argued that a mandatory agreement requires customers to submit claims to binding individual arbitration rather than proceeding in court.